Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesA review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin
Canadian Journal of Gastroenterology, 10/12/09
N Mistry et al. – Drug–induced cutaneous eruptions are named among the most common side effects of many medications. Thus, cutaneous drug eruptions are a common cause of morbidity and mortality, especially in hospital settings. The present article reviews different presentations of druginduced cutaneous eruptions, with a focus on eruptions reported secondary to the use of interferon and ribavirin.
Related Articles
High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment
Journal of Virology, 10/19/09
Relevance Score: 85%
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders
Hepatology, 10/26/09
Relevance Score: 84%
Treatment of insulin resistance with metformin in naive genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin
Hepatology, 10/22/09
Relevance Score: 84%
Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression
Digestive and Liver Diseases, 10/12/09
Relevance Score: 84%
Pegylated IFN-alpha-2a and ribavirin in the treatment of hepatitis C
Expert Review of Anti-infective Therapy, 10/09/09
Relevance Score: 84%
Today in Derm Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Temperature modulated histamine-itch in lesional and nonlesional skin in atopic eczema a combined psychophysical and neuroimaging study
Allergy, 12/18/09
Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
Journal of the European Academy of Dermatology and Venereology, 12/17/09
Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses
Immunology & Cell Biology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor